Satisfying the Requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services

Journal of the American College of Radiology

Volumn 5, Issue 3, 2008, Pages 189-192

  Smith, John J ^a   Henderson, Jennifer A ^a  

^a Hogan and Hartson   (United States)

Author keywords

Centers for Medicare and Medicare Services; clearance or approval; Clinical data; coverage and payment; Food and Drug Administration

Indexed keywords

CLINICAL STUDY; DIAGNOSTIC IMAGING; FOOD AND DRUG ADMINISTRATION; HEALTH CARE; HUMAN; IMAGING SYSTEM; MARKETING; MEDICARE; PROSPECTIVE PAYMENT; PURCHASING; REVIEW; SATISFACTION;

EID: 39749137700     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2007.09.005     Document Type: Review

References (7)

1. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 201(h).
2. 42 U.S.C. 1395y (2006).
3. Smith J.J., Maida T.R., and Henderson J.A. Medicare coverage for new medical technology: the basics of Health Care Financing Administration Policy. AJR Am J Roentgenol 176 (2001) 313-316
4. Centers for Medicare and Medicaid Services. Decision memo for lumbar artificial disc replacement, CAG-00292N (2006) May 16
5. Thomas K. Medicare panel calls for outcomes data on non-invasive coronary imaging, 32(21). The Gray Sheet 4 (2006) May 22
6. Dobson J. CMS analyzing national coverage of computed tomographic angiography, 33(25). The Gray Sheet 11 (2007) June 18
7. Taft C. CMS signals more potential cuts for Medicare imaging payments, 32(47). The Gray Sheet 11 (2006) November 20